Show only
Gilbert Shen, CPA
Chinese Tax Reg­u­la­tion Up­date - Septem­ber 2018
22 Nov 18
CMS Glob­al Life Sci­ences & Health­care For­um
The Big Bang - Tech­no­lo­gies re­volu­tion­ising Life Sci­ences...
China es­tab­lishes a new block­chain tri­al zone in Hain­an
On 30 Septem­ber 2018, the Hain­an Pro­vin­cial In­dustry and In­form­a­tion Tech­no­logy De­part­ment ap­proved the es­tab­lish­ment of the Hain­an Free Trade Zone (Port) Block­chain Tri­al Zone (the “Hain­an Block­chain Zone”) to en­cour­age in­nov­a­tion and pro­mote the ap­plic­a­tion.
Dr. Christoph Schröder
In­ter­na­tion­al CMS team as­sists Chinese cable man­u­fac­turer...
China Life Sci­ences & Health­care Monthly Up­date – Septem­ber 2018
NHC guidelines on the clin­ic­al ap­plic­a­tion of new anti-tu­mour drugs, 21 Septem­ber The Na­tion­al Health Com­mis­sion (“NHC”) of the People’s Re­pub­lic of China (“PRC”) re­leased the Guidelines on the Clin­ic­al Ap­plic­a­tion of New Anti-tu­mour Drugs (“Guidelines”) on.
Dr Ul­rike Glueck Re­ceives Magno­lia Award
Awards and Rank­ings
China Tax Reg­u­la­tion Up­date - Septem­ber 2018
The latest de­vel­op­ment in China Tax Reg­u­la­tion mainly in­cludes: SAT An­nounce­ment [2018] No. 45: Sup­ple­ment­ary reg­u­la­tion of ex­ten­sion of valid­ity peri­od of tax loss of High New Tech­no­logy En­ter­prises (“HNTEs”) and Me­di­um- and Small-scale Sci­entif­ic and.
China Ac­cepts Over­seas Clin­ic­al Tri­al Data to Ex­ped­ite...
China In­sight - Life Sci­ences